PCHEM:MYXPETRONAS Chemicals Group Bhd. Analysis
Data as of 2026-06-12 - not real-time
MYR 5.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
PCHEM trades around MYR 5.6, sitting just above the 20‑day SMA (5.52) and marginally below the 50‑day SMA (5.59), while the 200‑day SMA (4.29) provides a strong long‑term floor. Technical indicators show a bullish MACD histogram (+0.023) and a neutral RSI (52), suggesting limited upside momentum but no immediate oversold condition. The stock is currently confined between a support level of MYR 5.21 and a resistance of MYR 5.90, with volume trending downward, which could constrain short‑term price moves. Fundamentally, revenue has contracted 8.4% YoY, profit margins are negative (-6.4%), and ROE is –4.2%, yet forward EPS is projected positive (0.154) and analysts maintain a “buy” consensus with a median target of MYR 6.0. The dividend yield of 1.21% is offset by an unsustainable payout ratio of 194%, raising concerns about dividend continuity. Volatility is high at 57% over the past 30 days and beta is negative (‑0.52), indicating the stock moves inversely to the broader market and may experience sharper swings in a risk‑on environment.
Valuation metrics place the current price above the DCF‑derived fair value of MYR 2.99 but near the analyst median target, suggesting the market is pricing in some recovery despite weak earnings. The combination of elevated volatility, modest growth prospects, and dividend sustainability issues points to a cautious stance: short‑term investors may consider holding while monitoring technical support, medium‑term investors should watch for earnings improvement, and long‑term holders face heightened risk from cyclical sector dynamics and valuation pressure.
Valuation metrics place the current price above the DCF‑derived fair value of MYR 2.99 but near the analyst median target, suggesting the market is pricing in some recovery despite weak earnings. The combination of elevated volatility, modest growth prospects, and dividend sustainability issues points to a cautious stance: short‑term investors may consider holding while monitoring technical support, medium‑term investors should watch for earnings improvement, and long‑term holders face heightened risk from cyclical sector dynamics and valuation pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram indicating short‑term momentum
- Price comfortably above immediate support (MYR 5.21)
- Decreasing volume limiting upside potential
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS turning positive and analyst target price above current level
- Persistently negative profit margins and revenue decline
- High volatility and inverse market beta increasing price uncertainty
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Current price exceeds DCF fair value, implying overvaluation
- Unsustainable dividend payout ratio and negative ROE
- Cyclical chemicals sector exposure and elevated long‑term risk
Key Metrics & Analysis
Financial Health
Revenue Growth-8.40%
Profit Margin-6.42%
P/E Ratio36.5
ROE-4.22%
ROA-0.98%
Debt/Equity14.42
P/B Ratio1.3
Op. Cash FlowMYR3.3B
Free Cash FlowMYR1.5B
Technical Analysis
TrendNeutral
RSI52.3
SupportMYR 5.21
ResistanceMYR 5.90
MA 20MYR 5.52
MA 50MYR 5.59
MA 200MYR 4.29
MACDBullish
VolumeDecreasing
Fear & Greed Index86.59
Valuation
Fair ValueMYR 3.00
Target PriceMYR 5.91
Upside/Downside5.54%
GradeFair
TypeBlend
Dividend Yield1.21%
Risk Assessment
Beta-0.52
Volatility57.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.